Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moisturization Efficacy of ChapStick Active Performance Unscented Lip Balm
NCT05109117Completed
- Sponsor
- Haleon
- Start
- Dec 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of CAP UnScented in xerosis cutis (2 arms), sponsored by Haleon. Primary endpoint: Mean Change From Baseline in Corneometer Measurements at 8 hours. Started Dec 2021; status: completed.
02
Drugs
CAP UnScented
03
Conditions
xerosis cutis
Beyond the preview
Go deeper on NCT05109117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109117.